Tourmaline Bio
Samia Siddiqui is a Senior Director Regulatory Strategy at Tourmaline Bio, with previous experience as Director Global Regulatory Affairs at The Janssen Pharmaceutical Companies of Johnson & Johnson. Samia holds a PhD in Biochemistry from Massachusetts Institute of Technology and a BA in Biochemistry and Religious Studies from University of Pennsylvania.
This person is not in any offices
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.